We are international

Call the IMF Hotline. We are here for you. The IMF Office is open from 8:00AM - 5:00PM PST, Monday-Friday.

If you have a question, call the IMF InfoLine at (800) 452-CURE (800-452-2873) in the US and Canada. The InfoLine is open from 9:00 - 4:00 PT Monday - Friday. Elsewhere call (818) 487-7455. You can also contact us via the web.
IMF - Home Page
previous     next      view all

The International Myeloma Foundation Applauds Bipartisan Introduction of Oral Parity Legislation

Legislation Works to Increase Patient Access to Anticancer Medications

ICYMI: Watch the replay of the IMWG Conference series.
Watch Drs. Brian Durie, Joseph Mikhael, Paul Richardson, and Ola Landgren discuss the latest trends in myeloma treatment.

Recored live at the IMWG summit Vienna, Austria June 10, 2015.

IMF Honors Pieter Sonneveld with the 2015 Robert A. Kyle Lifetime Achievement Award

Dr. Pieter Sonneveld is Chairman of the Dutch HOVON Myeloma Cooperative Group and he coordinates clinical trials in lymphoma, leukemia and multiple myeloma in The Netherlands. He is on the executive board of the European Hematology Association (EHA). He serves on the Scientific Advisory Boards of the IMF, the Myeloma UK Foundation, is a member of the Editorial Boards of more than eight major hematology publications, and is Associate Editor of Haematologica. He is Chairman of the European Myeloma Network. 

Watch the Top News from ASCO 2015
The IMF delivered highlights from the 51st annual meeting of the American Society of Clinical Oncology (ASCO) held May 29-June 2 in Chicago, Illinois via videos on our YouTube page. See overviews of the top news presented at ASCO from this great gathering of top physicians, like Mayo Clinic doctors Morie Gertz and Shaji Kumar. To watch the highlights, click here.

International Myeloma Foundation Brings Together 100 of the World’s Top Myeloma Experts June 8-10 in Vienna, Austria for 6th Annual Summit

Researchers, Clinicians and Advocates to Share Cutting-Edge Research To Improve Patients’ Lives and Lead to a Cure

Tonight's Medicare Advantage Webinar will not require registration. The meeting will begin at 7pm Eastern Time. Click Here
Tonight's Medicare Advantage Webinar will not require registration. The meeting will begin at 7pm Eastern Time. Click here: http://bit.ly/1Kmyeq4

Lifting the Veil of Hype Surrounding the Promise of Genomics
Has the promise of genetic research been overhyped? In his blog this week, IMF Chairman Dr. Brian Durie looks at this question, posed in a recent article by science writer David Dobbs. Years of disappointing genomic research has largely failed to halt the progression of most diseases. “We need a balance of caution and understanding before signing over all hope to big genomics,” writes Dr. Durie. To read blog click HERE.

Tune in to IMF Medicare Advantage Webinar on June 3
Please join IMF Advocacy team members on June 3, 2015 at 4 pm PT / 7 pm ET as we host an important webinar entitled "Medicare Advantage: An Overview." During this 60-minute webinar, Dr. Gretchen Jacobson of the Kaiser Family Foundation will present vital information about Medicare Advantage plans, and more specifically, explain the ways in which Advantage plans’ coverage differ from more traditional Medicare plans. If you or your family is interested in learning which types of coverage are best for you, don’t miss this webinar! To register, please click here.

The Tweets Have Been Tallied and We Want to Say Thanks!
Thank you to the many IMF social media followers who participated in the #DiscoverMyeloma campaign on Twitter, and of course, a big thanks to everyone at Takeda for their generous $30,000 donation! Takeda Oncology, a division of Takeda Pharmaceutical Company, ran a social media fundraising and awareness drive in March during Myeloma Awareness month, pledging $5 to the IMF for every tweet sent using the hashtag #DiscoverMyeloma. Well, the Tweets have been counted and there were 6,000 tweets (!) spreading the word, facts and resources about the fight against myeloma! “We’re so grateful to all for their daily participation and help in driving further awareness about myeloma with the larger community,” said Robin Tuohy, Senior Director of Support Groups for the IMF. “Now thanks to the combined efforts of each individual and the generosity of Takeda, the IMF has a wonderful donation to help us continue our mission to find a cure.”

Myeloma Immune Therapy Emerges as a Key Theme at ASCO 2015
In his blog this week, IMF Chairman Dr. Brian Durie reviews abstracts of the top myeloma studies to be presented at the 2015 annual meeting of the American Society of Clinical Oncology (ASCO). “Immune therapy in myeloma will likely dominate the news,” writes Dr. Durie of the event, which begins May 29th in Chicago. Click HERE to read his blog.

previous     next      view all